Los Angeles Capital Management LLC Has $16.79 Million Stake in Inspire Medical Systems, Inc. (NYSE:INSP)

Los Angeles Capital Management LLC raised its stake in Inspire Medical Systems, Inc. (NYSE:INSP - Free Report) by 110.7% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 90,542 shares of the company's stock after purchasing an additional 47,563 shares during the period. Los Angeles Capital Management LLC owned 0.30% of Inspire Medical Systems worth $16,785,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently modified their holdings of INSP. B. Metzler seel. Sohn & Co. Holding AG acquired a new position in shares of Inspire Medical Systems in the third quarter valued at about $1,929,000. Thrivent Financial for Lutherans grew its stake in shares of Inspire Medical Systems by 39.7% in the third quarter. Thrivent Financial for Lutherans now owns 110,580 shares of the company's stock valued at $23,337,000 after acquiring an additional 31,444 shares in the last quarter. Merit Financial Group LLC acquired a new position in shares of Inspire Medical Systems in the fourth quarter valued at about $313,000. Principal Financial Group Inc. grew its stake in shares of Inspire Medical Systems by 3,812.6% in the third quarter. Principal Financial Group Inc. now owns 141,089 shares of the company's stock valued at $29,777,000 after acquiring an additional 137,483 shares in the last quarter. Finally, Public Employees Retirement System of Ohio grew its stake in shares of Inspire Medical Systems by 9.4% in the third quarter. Public Employees Retirement System of Ohio now owns 36,361 shares of the company's stock valued at $7,674,000 after acquiring an additional 3,125 shares in the last quarter. 94.91% of the stock is currently owned by institutional investors and hedge funds.

Remove Ads

Analysts Set New Price Targets

Several equities analysts recently commented on INSP shares. Piper Sandler decreased their price target on shares of Inspire Medical Systems from $260.00 to $233.00 and set an "overweight" rating on the stock in a research note on Monday, February 10th. Bank of America upgraded shares of Inspire Medical Systems from a "neutral" rating to a "buy" rating and increased their price objective for the stock from $220.00 to $255.00 in a research note on Wednesday, November 20th. Morgan Stanley reduced their price objective on shares of Inspire Medical Systems from $230.00 to $220.00 and set an "overweight" rating on the stock in a research note on Tuesday, February 11th. Wells Fargo & Company reduced their price objective on shares of Inspire Medical Systems from $198.00 to $195.00 and set an "equal weight" rating on the stock in a research note on Tuesday, February 11th. Finally, Stifel Nicolaus reduced their price objective on shares of Inspire Medical Systems from $200.00 to $190.00 and set a "hold" rating on the stock in a research note on Tuesday, January 21st. Three analysts have rated the stock with a hold rating and eight have issued a buy rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and a consensus price target of $228.82.

Inspire Medical Systems Stock Up 0.8 %

Shares of INSP stock traded up $1.54 on Friday, reaching $185.56. The company had a trading volume of 414,828 shares, compared to its average volume of 607,237. The stock has a market capitalization of $5.51 billion, a PE ratio of 107.26, a price-to-earnings-growth ratio of 2.86 and a beta of 1.32. Inspire Medical Systems, Inc. has a one year low of $123.00 and a one year high of $257.40. The business's 50-day moving average is $187.87 and its 200 day moving average is $193.10.

Inspire Medical Systems (NYSE:INSP - Get Free Report) last issued its quarterly earnings data on Monday, February 10th. The company reported $1.15 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.74 by $0.41. Inspire Medical Systems had a net margin of 6.67% and a return on equity of 8.19%. On average, sell-side analysts forecast that Inspire Medical Systems, Inc. will post 2.16 earnings per share for the current fiscal year.

Insider Activity at Inspire Medical Systems

In other Inspire Medical Systems news, CTO John Rondoni sold 583 shares of the stock in a transaction that occurred on Tuesday, February 11th. The shares were sold at an average price of $170.49, for a total transaction of $99,395.67. Following the completion of the sale, the chief technology officer now owns 10,424 shares of the company's stock, valued at approximately $1,777,187.76. This represents a 5.30 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, insider Randy Ban sold 25,584 shares of the stock in a transaction that occurred on Thursday, February 13th. The shares were sold at an average price of $183.50, for a total transaction of $4,694,664.00. Following the sale, the insider now directly owns 7,259 shares of the company's stock, valued at $1,332,026.50. This represents a 77.90 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 26,225 shares of company stock worth $4,806,530 in the last quarter. 4.10% of the stock is owned by insiders.

About Inspire Medical Systems

Inspire Medical Systems, Inc, a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA.